Additionally, adiponectin, which is well established as a biomarker for type 2 diabetes and coronary artery disease, may be useful in future studies examining cardiometabolic risk in PCOS [75,148]. The gene discussed is ADIPOQ; the disease is polycystic ovary syndrome.